肿瘤坏死因子抑制剂治疗与中轴型脊柱关节炎患者影像学脊柱进展的时间偏移性延缓相关
该研究基于德国脊柱关节炎起始队列中243例中轴型脊柱关节炎患者、随访10年且至少两套间隔≥2年的脊柱X线片,按改良Stoke强直性脊柱炎脊柱评分(mSASSS)评估。结果显示当前2年间隔内TNFi治疗与影像学脊柱进展延缓无关,而前一个2年间隔内TNFi治疗与mSASSS进展减少显著相关,提示TNFi对影像学脊柱进展存在时间偏移效应,在治疗开始后第2至4年间变得明显。
要点
- 当前2年间隔内TNFi治疗与影像学脊柱进展延缓无关(β=-0.02,95%CI -0.37至0.34)。
- 前一个2年间隔内TNFi治疗与mSASSS进展减少显著相关(β=-0.58,95%CI -1.02至-0.13)。
- TNFi对影像学脊柱进展的时间偏移效应在治疗开始后第2至4年间变得明显。
核心结论
- TNFi治疗与中轴型脊柱关节炎影像学脊柱进展存在时间偏移效应,该效应在治疗开始后第2至4年间变得明显。
研究设计与样本
- 研究纳入德国脊柱关节炎起始队列中243例中轴型脊柱关节炎患者,随访10年,要求至少两套间隔至少2年的脊柱X线片。
- 脊柱X线片由三名经过培训并校准的阅片者按改良Stoke强直性脊柱炎脊柱评分(mSASSS)评估。
- 采用纵向广义估计方程分析当前TNFi、既往TNFi与2年间mSASSS绝对变化评分所定义的影像学脊柱进展之间的关联。
主要发现
- 当前2年间隔内TNFi治疗与影像学脊柱进展延缓无关:任何疗程β=-0.02(95%CI -0.37至0.34),疗程≥12个月β=-0.17(95%CI -0.54至0.20),均校正性别、强直性脊柱炎疾病活动度评分、吸烟、明确影像学骶髂关节炎、基线mSASSS和非甾体抗炎药使用。
- 前一个2年间隔内TNFi治疗与mSASSS进展减少显著相关,尤其在前一个和当前2年间隔均接受TNFi治疗的患者中明显:β=-0.58(95%CI -1.02至-0.13),校正同上变量。
关键数值与推荐
- 影像学脊柱进展定义为2年间mSASSS绝对变化评分。
- 当前2年间隔内任何TNFi治疗β=-0.02(95%CI -0.37至0.34),疗程≥12个月β=-0.17(95%CI -0.54至0.20)。
- 前一个2年间隔内TNFi治疗β=-0.58(95%CI -1.02至-0.13)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of the current study was to analyse the association between treatment with tumour necrosis factor inhibitors (TNFi) and radiographic spinal progression in patients with axial spondyloarthritis (axSpA) from a long-term inception cohort. METHODS: A total of 243 patients with axSpA from the German Spondyloarthritis Inception Cohort with at least two sets of spinal radiographs obtained at least 2 years apart during a 10-year follow-up were included. Spinal radiographs were evaluated by three trained and calibrated readers according to the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS). The association between the current TNFi, previous TNFi and radiographic spinal progression defined as the absolute mSASSS change score over 2 years was analysed using longitudinal generalised estimating equations analysis. RESULTS: TNFi treatment in the current 2-year interval was not associated with retardation of radiographic spinal progression (β=-0.02 (95% CI -0.37 to 0.34) and -0.17 (95% CI -0.54 to 0.20) for any and ≥12 months treatment duration, respectively, adjusted for sex, the Ankylosing Spondylitis Disease Activity Score, smoking, presence of definite radiographic sacroiliitis, mSASSS at baseline and non-steroidal anti-inflammatory drug intake). TNFi treatment in the previous 2-year interval, was, however, significantly associated with reduction of mSASSS progression, which was especially evident in patients who received TNFi in the previous and in the current intervals: β=-0.58 (95% CI -1.02 to -0.13), adjusted for the same variables. CONCLUSION: TNFi treatment was associated with a time-shifted effect on radiographic spinal progression in axSpA that became evident between years 2 and 4 after treatment initiation.
引用
- Torgutalp M, Rios Rodriguez V, Dilbaryan A, et al. Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis. Ann Rheum Dis. 2022. PMID: 35697486. doi:10.1136/annrheumdis-2022-222324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。